QT dispersion and components of the QT interval in ischaemia and infarction.
PD Higham, SS Furniss, RW Campbell - Heart, 1995 - heart.bmj.com
OBJECTIVE--To evaluate changes in QT dispersion and components of the QT interval in
patients admitted with unstable angina and acute myocardial infarction and to study the …
patients admitted with unstable angina and acute myocardial infarction and to study the …
Safe sedation in modern cardiological practice
SS Furniss, JR Sneyd - Heart, 2015 - heart.bmj.com
Safe sedation is fundamental to many modern cardiological procedures, and following the
publication of the report on safe sedation by the Academy of Medical Royal Colleges, this …
publication of the report on safe sedation by the Academy of Medical Royal Colleges, this …
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial
…, N Sulke, E Dolan, M van der Giet, J Hoyer, SS Furniss… - The Lancet, 2015 - thelancet.com
Background Hypertension contributes to cardiovascular morbidity and mortality. We assessed
the safety and efficacy of a central iliac arteriovenous anastomosis to alter the mechanical …
the safety and efficacy of a central iliac arteriovenous anastomosis to alter the mechanical …
Errors in manual measurement of QT intervals.
…, NB McLaughlin, JP Bourke, JC Doig, SS Furniss… - Heart, 1994 - heart.bmj.com
OBJECTIVE--To quantify the errors associated with manual measurement of QT intervals and
to determine the source of the errors. DESIGN--A randomised study of QT measurement by …
to determine the source of the errors. DESIGN--A randomised study of QT measurement by …
Delayed cure despite early recurrence after pulmonary vein isolation for atrial fibrillation
D O'Donnell, SS Furniss, A Dunuwille… - American Journal of …, 2003 - ajconline.org
Delayed Cure Despite Early Recurrence After Pulmonary Vein Isolation for Atrial Fibrillation
gressive use of this drug by electrophysiologists. 4 Electrophysiologists also have more …
gressive use of this drug by electrophysiologists. 4 Electrophysiologists also have more …
Are implantable cardiac monitors the 'gold standard'for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using …
SJ Podd, C Sugihara, SS Furniss, N Sulke - EP Europace, 2016 - academic.oup.com
Aims Implantable devices are widely accepted, but not proven, to be the most reliable
monitoring method to assess atrial fibrillation (AF) therapies. We compared REVEAL ® XT …
monitoring method to assess atrial fibrillation (AF) therapies. We compared REVEAL ® XT …
Interatrial transseptal electrical conduction: comparison of patients with atrial fibrillation and normal controls
…, JP Bourke, SS Furniss - Journal of cardiovascular …, 2002 - Wiley Online Library
Interatrial Electrical Conduction. Introduction: This study analyzed the electrophysiologic
properties of interatrial transseptal electrical conduction at Bachmann's bundle and the ostium …
properties of interatrial transseptal electrical conduction at Bachmann's bundle and the ostium …
Central iliac arteriovenous anastomosis for uncontrolled hypertension: one-year results from the ROX CONTROL HTN trial
…, E Dolan, M van der Giet, J Hoyer, SS Furniss… - …, 2017 - Am Heart Assoc
Creation of a central iliac arteriovenous anastomosis using a novel nitinol coupler device
results in an immediate, significant reduction of blood pressure (BP). We present efficacy and …
results in an immediate, significant reduction of blood pressure (BP). We present efficacy and …
Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function.
RK Saran, M Been, SS Furniss, T Hawkins, DS Reid - Heart, 1990 - heart.bmj.com
The usefulness of a reduction in ST segment elevation to predict coronary reperfusion in
myocardial infarction remains uncertain. ST segment changes and angiographic findings were …
myocardial infarction remains uncertain. ST segment changes and angiographic findings were …
First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS …
SJ Podd, N Freemantle, SS Furniss, N Sulke - Europace, 2016 - academic.oup.com
Aims To assess the efficacy of BMS 914392 on atrial fibrillation (AF) burden reduction in 20
patients with pacemakers and paroxysmal atrial fibrillation (PAF). BMS 914392 is a potent, …
patients with pacemakers and paroxysmal atrial fibrillation (PAF). BMS 914392 is a potent, …